Home > Balance Sheet > ADVANCED ENZYME TECHNOLOGIES

ADVANCED ENZYME TECHNOLOGIES
Total Non-Current Liabilities

    Back to Balance Sheet
ADVANCED ENZYME TECHNOLOGIES is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for ADVANCED ENZYME TECHNOLOGIES
Please provide your vote to see the results

ADVANCED ENZYME TECHNOLOGIES Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Total Non-Current Liabilities ₹44 Cr₹46 Cr₹44 Cr₹49 Cr₹59 Cr

What is the latest Total Non-Current Liabilities ratio of ADVANCED ENZYME TECHNOLOGIES ?

The latest Total Non-Current Liabilities ratio of ADVANCED ENZYME TECHNOLOGIES is ₹44 Cr based on Mar2026 Consolidated results.
Year Total Non-Current Liabilities
Mar2026₹44 Cr
Mar2025₹46 Cr
Mar2024₹44 Cr
Mar2023₹49 Cr
Mar2022₹59 Cr

How is Total Non-Current Liabilities of ADVANCED ENZYME TECHNOLOGIES Trending?

Years Total Non-Current Liabilities % Change
Mar2026 ₹44 Cr
-4.76
Mar2025 ₹46 Cr
5.70
Mar2024 ₹44 Cr
-10.30
Mar2023 ₹49 Cr
-17.87
Mar2022 ₹59 Cr -

Compare Total Non-Current Liabilities of peers of ADVANCED ENZYME TECHNOLOGIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ADVANCED ENZYME TECHNOLOGIES ₹2,961.3 Cr 6.5% -6.9% -16.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹422,991.0 Cr 1.1% -4.2% 4.1% Stock Analytics
DIVIS LABORATORIES ₹256,310.0 Cr 7.5% 1.3% 45.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹173,604.0 Cr 1.8% -6.3% 26.1% Stock Analytics
DR REDDYS LABORATORIES ₹111,722.0 Cr 9.3% 9.5% 4.3% Stock Analytics
CIPLA ₹109,628.0 Cr 1.5% -2.3% -17.3% Stock Analytics


ADVANCED ENZYME TECHNOLOGIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
ADVANCED ENZYME TECHNOLOGIES

6.5%

-6.9%

-16.2%

SENSEX

1.2%

0.4%

-12.2%


You may also like the below Video Courses